Anti-reflux mucosectomy is associated with better short-term symptoms than double-dose proton pump inhibitor in reflux esophagitis patients

doi:10.4240/wjgs.119941

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 6

This Article

(27)

(18)

(0)

(240)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Surg. Jun 27, 2026; 18(6): 119941
Published online Jun 27, 2026. doi: 10.4240/wjgs.119941

Full Size Figure Download Figure

Figure 3 Quality of life outcomes of anti-reflux mucosectomy proton pump inhibitor and double-dose proton pump inhibitor groups in terms of reflux symptom index, gastroesophageal reflux disease-health-related quality of life, gastroesophageal reflux disease questionnaire and reflux disease questionnaire scores preoperatively and at different time points postoperatively. PPI: Proton pump inhibitor; ARMS: Anti-reflux mucosectomy; RSI: Reflux symptom index; GERDQ: Gastroesophageal reflux disease questionnaire; GERD-HRQL: Gastroesophageal reflux disease-health-related quality of life; RDQ: Reflux disease questionnaire.

Citation: Jiang WJ, Liu J, Liu YL, Tang MD, Sheng Y, Wang YT. Anti-reflux mucosectomy is associated with better short-term symptoms than double-dose proton pump inhibitor in reflux esophagitis patients. World J Gastrointest Surg 2026; 18(6): 119941
URL: https://www.wjgnet.com/1948-9366/full/v18/i6/119941.htm
DOI: https://dx.doi.org/10.4240/wjgs.119941

Jiang WJ, Liu J, Liu YL, Tang MD, Sheng Y, Wang YT. Anti-reflux mucosectomy is associated with better short-term symptoms than double-dose proton pump inhibitor in reflux esophagitis patients. World J Gastrointest Surg 2026; 18(6): 119941 [DOI: 10.4240/wjgs.119941]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.